GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BIO-FD&C Co Ltd (XKRX:251120) » Definitions » Research & Development

BIO-FD&C Co (XKRX:251120) Research & Development : ₩1,452 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is BIO-FD&C Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. BIO-FD&C Co's Research & Development for the three months ended in Mar. 2024 was ₩509 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ₩1,452 Mil.

BIO-FD&C Co Research & Development Historical Data

The historical data trend for BIO-FD&C Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BIO-FD&C Co Research & Development Chart

BIO-FD&C Co Annual Data
Trend Dec15 Dec16 Dec18 Dec19 Dec20 Dec21 Dec22
Research & Development
Get a 7-Day Free Trial 1,254.60 936.57 738.83 815.90 1,449.27

BIO-FD&C Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 486.13 243.86 361.05 337.85 509.12

BIO-FD&C Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩1,452 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BIO-FD&C Co  (XKRX:251120) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

BIO-FD&C Co Research & Development Related Terms

Thank you for viewing the detailed overview of BIO-FD&C Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

BIO-FD&C Co (XKRX:251120) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BIO-FD&C Co Ltd (XKRX:251120) » Definitions » Research & Development
Comparable Companies
XKRX:389030 XKRX:067370 XKRX:353810 XKRX:234690 XKRX:203400 XKRX:140610 XKRX:166480 XKRX:284620 XKRX:308080 XKRX:365270 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
30, Songdomirae-ro, Yeonsu-gu, 509-512, B07, A-dong, Smartvalley, Incheon, KOR
Website
http://www.biofdnc.com
BIO-FD&C Co Ltd is engaged in dealing with anti-aging and health materials using sustainable bio-cultivation technology. Its products include Plant cell, Peptide, Herbal Extract and Biomolecule.

BIO-FD&C Co (XKRX:251120) Headlines

No Headlines